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Background
Somatic stem cells are the basic tools of regenerative
medicine and gene therapy, providing unique opportu-
nities for the therapy of genetic and acquired disorders.
The molecular mechanisms underlying fundamental
characteristics of human somatic stem cells, such as self-
renewal, commitment and differentiation, are still poorly
understood. A better knowledge of these mechanisms is
crucial to the understanding of stem cell biology and to
the development of stem cell-based therapies. The
rapidly expanding information on the structural and
functional characteristics of the human genome allows
the development of genome-wide approaches to investi-
gate the molecular circuitry wiring the genetic and epige-
netic programs of somatic stem cells. High-throughput
approaches are essential to study the transcriptome, the
epigenome and the usage of regulatory elements in the
genome.
Materials and methods
The study presented here aims at defining the transcrip-
tional and epigenetic profile of human hematopoietic
stem/progenitor cells (HSPCs) and their committed,
myeloid and erythroid progeny. For this purpose, high-
throughput technologies were exploited such as:
- Cap Analysis of Gene Expression (CAGE), which
allows genome-wide mapping of active promoters;
- Chromatin Immunoprecipitation coupled to deep
sequencing technology (ChIP-Seq), for a genome-wide
analysis of chromatin signatures typical of regulatory
elements;
- Retroviral scanning, a novel technology based on the
target site specificity of gamma-retroviral pre-integration
complexes, to map transcriptionally active regulatory
sequences.
Results
CAGE analysis allowed to define >9,000 active promoters
in HSPCs and their progeny. Around 500 transcripts were
generated by the usage of alternative promoters, in some
cases in a lineage-specific fashion. The different cell types
shared most of the promoters, suggesting that the tran-
scriptional state is largely maintained in early hematopoie-
tic progenitors and precursors. Therefore, only a relatively
small number of differentially used promoters defines the
identity of hematopoietic cells at different stages of differ-
entiation. 85% of the active promoters in each cell type
were associated with known genes, whereas 13% of the
transcripts identified by CAGE were classified as novel.
Surprisingly, a significantly higher proportion (30%) of
cell-specific promoters was not annotated. These novel
transcripts are possibly involved in HSPC self-renewal,
commitment and differentiation.
To obtain a genome-wide description of the transcrip-
tional regulatory regions, we performed ChIP-seq analysis
for histone methylations typical of active promoters and
enhancers, H3K4me3 and H3K4me1, respectively. More
than 15,000 putative promoters and 55,000 enhancers
were discovered in all cell types analyzed. As expected,
most of the promoters identified by CAGE overlapped
with H3K4me3 peaks. Interestingly, a small fraction of
TSSs was found in regions highly enriched in H3K4me1,
indicating the presence of potential “enhancer RNA”.
Finally, retroviral scanning was used to map about 3000
activeenhancers involved in the control of growth, differ-
entiation and development of hematopoietic cells. More
than 60% of these regulatory regions were differentially
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Conclusions
Overall, this study provided an overview of the differential
transcriptional programs of HSPCs and committed pre-
cursors and represents a unique source of genes and regu-
latory regions involved in self-renewal, commitment and
differentiation of human hematopoietic stem cells and
their progeny.
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